title: [Cutaneous side effects of clinically relevant cytokine therapies].
authors.affiliation: Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Charité, Humboldt-Universität zu Berlin.
authors.forename: U
authors.initials: U
authors.lastname: Trefzer
authors.forename: M
authors.initials: M
authors.lastname: Hofmann
authors.forename: W
authors.initials: W
authors.lastname: Sterry
mesh_terms: D000505:Alopecia / Q000139:chemically induced; D016207:Cytokines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000627:therapeutic use; D014657:Vasculitis / Q000139:chemically induced; D014820:Vitiligo / Q000139:chemically induced
chemical_list: D016207:Cytokines; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D007372:Interferons